Suzhou MedicalSystem Technology Co., Ltd. announced that it has received CNY 727.599565 million in funding from Shanghai Yuehai Asset Management Co., Ltd., Fullgoal Fund Management Co., Ltd., Minsheng Securities Co., Ltd., Investment Arm and other investors
November 22, 2020
Share
On November 23, 2020, Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) closed the transaction. The company issued 19,863,488 shares at a price of CNY 36.63 per share for gross proceeds of CNY 727,599,565.44 in the transaction. The company received net proceeds of CNY 706,637,311.54 in the transaction.
Suzhou MedicalSystem Technology Co., Ltd. is a China-based company principally engaged in the research and development of clinic information system (CIS) software and the provision of overall solution of clinical-informatization. The Company's products mainly include DoCare series clinic medical management system software and clinical-informatization overall solutions. Its DoCare series clinic medical management system software include DoCare anesthesia clinical information system, DoCare severe clinical information system, DoCare operation medical behavior management system, DoCare emergency clinical information system, as well as DoCare pre hospital first aid clinical information system. Its products are mainly applied in hospitals. The Company mainly operates its business in domestic market, with East China, Northeast, North China and Central China as its major markets.
Suzhou MedicalSystem Technology Co., Ltd. announced that it has received CNY 727.599565 million in funding from Shanghai Yuehai Asset Management Co., Ltd., Fullgoal Fund Management Co., Ltd., Minsheng Securities Co., Ltd., Investment Arm and other investors
SUZHOU MEDICALSYSTEM TECHNOLOGY CO., LTD. 
